000 days 00 hours 00 minutes 00 seconds

Before the start of the


OCT. 25-29, 2021

In the aftermath of the biggest health crisis in recent history, the Galien Week of Innovation is back with an exceptional lineup of speakers who will boil-down return-on-experience and global data, share their vision for post-pandemic strategies and benchmarks, and debate burning issues in global human health.

REGISTER TODAY

Galien Forum 2021 Speakers

Scott Armstrong

Scott Armstrong
Chairman, Pediatric Oncology at Dana-Farber Cancer Institute and President, Dana-Farber/ Boston Children’s Hospital Cancer and Blood Disorders Center

Stephane Bancel, CEO, Moderna

Stephane Bancel
CEO, Moderna

Bar-Zohar

Danny Bar-Zohar
Global Head of Development, Merck Healthcare KGaA

Albert Bourla, CEO, Pfizer

Albert Bourla
Chairman and CEO, Pfizer

Robert Bradway, Chairman & CEO, Amgen

Robert Bradway
Chairman & CEO, Amgen

Giovanni Caforio, Chairman & CEO, Bristol Myers Squibb

Giovanni Caforio
Chairman & CEO, Bristol Myers Squibb

Robert M. Califf

Robert M. Califf
Head of Clinical Policy and Strategy for Verily and Google Health; Adjunct Professor, Duke University and Stanford UniversityFormer FDA Deputy Commissioner to Barack Obama

Sue Desmond-Hellmann

Sue Desmond-Hellmann
Prix Galien USA Committee Chair; Former Chief Executive Officer of the Bill & Melinda Gates Foundation

Mikael Dolsten
Chief Scientific Officer & President, WW Research, Development and Medical, Pfizer

Cristina Durán
Chief Digital Health Officer, R&D, AstraZeneca

Anthony S. Fauci

Anthony S. Fauci
Director, National Institute of Allergy and Infectious Diseases & Chief Advisor to the President of the United States

Ken Frazier, CEO, Merck & Co.

Ken Frazier
Executive Chairman of the Board of Directors, Merck & Co., Inc.

Laurie Glimcher

Laurie Glimcher
President & CEO, Dana-Farber Cancer Institute;
Professor of Medicine, Harvard Medical School

Alex Gorsky, CEO, J&J

Alex Gorsky
Chairman and Board of Directors & CEO, Johnson & Johnson

Ann Graybiel

Ann Graybiel
Institute Professor at MIT, Department of Brain and Cognitive Science

Dan Grossman
Managing Director and Senior PartnerBoston Consulting Group

Sebastian Guth
President of Pharmaceuticals, Americas Region, Bayer U.S. LLC

Samit Hirawat
Executive Vice President, Chief Medical Officer, Global Drug Development, Bristol Myers Squibb

William G. Kaelin

William Kaelin
Sidney Farber Professor of Medicine, Harvard Medical School and Dana-Farber Cancer Institute

Hon. Patrick J. Kennedy

Hon. Patrick J. Kennedy
Former U.S. Representative (D-RI); Founder, The Kennedy Forum; Former Member, President’s Commission on Combating Drug Addiction and the Opioid Crisis; Co-Founder, One Mind; Co-Founder, Mental Health for US

Crystal L Mackall

Crystal L Mackall
Ernest and Amelia Gallo Family Professor of Pediatrics and Medicine, Director, Stanford Center for Cancer Cell Therapy. Director, Parker Institute for Cancer Immunotherapy at Stanford, Associate Director, Stanford Cancer Institute, Stanford University

Joel Marcus
Executive Chairman & Founder, Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments; Co-Founder, Alexandria Summit

Michelle McMurry-Heath
President & CEO, BIO

Michelle Longmire

Michelle Longmire
Co-Founder and CEO, Medable

Michel Pairet

Michel Pairet
Board of Managing Directors – Innovation, Boehringer Ingelheim

Alexandra Von Plato
CEO, Publicis Health

Andy Plump

Andy Plump
President, Research & Development, Takeda Pharmaceuticals Company Ltd.

Leonard Schleifer

Leonard Schleifer
CEO, Regeneron

Richard Pops

Richard Pops
Chairman & Chief Executive Officer, Alkermes

MaryAnne Rizk

MaryAnne Rizk
Managing Partner, Rizk Management Consulting

Michael Rosenblatt
Co-Chair Galien Forum;
Senior Partner, Flagship Pioneering

Dan_Skovronsky

Daniel Skovronsky
President, Lilly Research Laboratories; Chief Scientific & Medical Officer, Eli Lilly and Company

Pascal Soriot
CEO, AstraZeneca

Jeffrey Spaeder

Jeffrey Spaeder
Global Chief Medical and Scientific Officer, IQVIA

Julie Sweet

Julie Sweet
CEO & Chair of the Board, Accenture

Marti Taylor

Marti Taylor
President & CEO, OneFifteen

Michel Vounatsos
Chairman and CEO, Biogen

Lynne Zydowsky
Chief of Science, Alexandria Real Estate Equities, Inc. & Alexandria Venture Investments; President & Co-Founder Alexandria Summit